Vireo Growth Inc. (CSE:VREO)
Canada · Delayed Price · Currency is CAD 14.75
+0.16 (1.10%)
At close: Aug 28, 2026
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of CAD 720.12 million as of August 28, 2026. Its market cap has decreased by -20.19% in one year.
Market Cap
720.12M
Enterprise Value
1.26B
Revenue
726.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.75
ChartMarket Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 394.96M to 720.12M, an increase of 82.33%. That is a compound annual growth rate of 8.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 720.12M | -18.71% |
| Dec 31, 2025 | 885.87M | 197.97% |
| Dec 31, 2024 | 297.31M | 551.82% |
| Dec 29, 2023 | 45.61M | 65.58% |
| Dec 30, 2022 | 27.55M | -90.04% |
| Dec 31, 2021 | 276.71M | 50.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.40B |
| Extendicare | 3.00B |
| Sienna Senior Living | 2.37B |
| Green Thumb Industries | 2.29B |
| Bright Minds Biosciences | 1.02B |
| DRI Healthcare Trust | 967.35M |
| Knight Therapeutics | 958.74M |
| Eupraxia Pharmaceuticals | 670.27M |